GLOBUS MEDICAL INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for GLOBUS MEDICAL INC (GMED), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are GMED insiders buying or selling?
GLOBUS MEDICAL INC insiders reported 3 open-market buys ($99.8K) and 71 sells ($291.5M) across 74 Form 4 filings — a net selling position of $291.4M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 9, 2026)
Insider sentiment
Net sellingNet insider flow of $291.4M in net selling.
Recent GMED insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | David D Davidar | Director | Sale | 25.0K | $80.76 | $2.0M |
| Feb 27, 2026 | Kelly Huller | EVP, GC, Corporate Secretary | Sale | 20.0K | $94.50 | $1.9M |
| Feb 17, 2026 | Kelly Huller | EVP, GC, Corporate Secretary | Sale | 10.0K | $87.67 | $876.7K |
| Jan 12, 2026 | Kyle Kline | Senior Vice President, CFO | Sale | 3.6K | $101.10 | $363.4K |
| Jan 12, 2026 | Leslie V Norwalk | Director | Sale | 2.0K | $101.10 | $202.2K |
| Dec 16, 2025 | Leslie V Norwalk | Director | Sale | 4.0K | $88.85 | $355.4K |
| Dec 4, 2025 | Kyle Kline | Senior Vice President, CFO | Sale | 18.5K | $90.00 | $1.7M |
| Nov 28, 2025 | Kelly Huller | SVP, GC, Corporate Secretary | Sale | 7.5K | $90.00 | $675.0K |
| Nov 13, 2025 | David D Davidar | Director | Sale | 25.0K | $86.00 | $2.2M |
| Nov 13, 2025 | Stephen T Zarrilli | Director | Sale | 25.0K | $84.29 | $2.1M |
| Nov 10, 2025 | Ann D Rhoads | Director | Sale | 10.0K | $81.80 | $818.0K |
| Sep 16, 2025 | Ann D Rhoads | Director | Sale | 10.0K | $58.46 | $584.6K |
| Mar 4, 2025 | Ann D Rhoads | Director | Sale | 7.5K | $78.68 | $590.1K |
| Jan 14, 2025 | Keith W Pfeil | COO, CFO | Sale | 14.2K | $88.29 | $1.3M |
| Dec 4, 2024 | Kelly Huller | SVP, GC, Corporate Secretary | Sale | 2.5K | $87.00 | $217.5K |
| Nov 25, 2024 | David D Davidar | Director | Sale | 40.0K | $85.00 | $3.4M |
| Nov 25, 2024 | Dan Lemaitre | Director | Sale | 14.4K | $85.00 | $1.2M |
| Nov 25, 2024 | Daniel T Scavilla | President, CEO | Sale | 130.0K | $85.00 | $11.1M |
| Nov 8, 2024 | Daniel T Scavilla | President, CEO | Sale | 60.0K | $80.02 | $4.8M |
| Nov 8, 2024 | Kelly Huller | SVP, GC, Corporate Secretary | Sale | 5.0K | $81.01 | $405.1K |
| Oct 18, 2024 | David D Davidar | Director | Sale | 50.0K | $75.04 | $3.8M |
| Sep 17, 2024 | Ann D Rhoads | Director | Sale | 15.0K | $70.36 | $1.1M |
| Sep 17, 2024 | David D Davidar | Director | Sale | 25.0K | $70.46 | $1.8M |
| Jul 15, 2024 | Leslie V Norwalk | Director | Sale | 1.0K | $70.00 | $70.0K |
| May 14, 2024 | Dan Lemaitre | Director | Sale | 63.3K | $64.61 | $4.1M |
Showing the 25 most recent of 74 Form 4 filings for GLOBUS MEDICAL INC.
Most active GMED insiders
- Kelly Huller16 filings
- David D Davidar10 filings
- Keith W Pfeil9 filings
- James R Tobin6 filings
- Ann D Rhoads4 filings
Ask anything about GMED insider activity
Use Trabud's AI agent to query GLOBUS MEDICAL INC's Form 4 history in plain English — "Show me GMED CEO purchases this year" or compare it against any other ticker.
Open the AI agentGMED insider trading FAQ
Are GLOBUS MEDICAL INC insiders buying or selling?
Across 74 SEC Form 4 filings, GLOBUS MEDICAL INC (GMED) insiders reported 3 open-market purchases totaling $99.8K and 71 sales totaling $291.5M. That is a net selling position of $291.4M.
How many insiders trade GMED stock?
16 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for GLOBUS MEDICAL INC. The most recent filing was accepted on Jun 9, 2026.
Where does Trabud get GMED insider trading data?
All GMED insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.